About this trial
This study aims to reduce disparities and the burden of lung cancer among African American smokers by supporting a Multiple-level intervention integrating lung cancer screening and smoking cessation (MILS), followed the NIH DEIA strategies using multilevel interventions that impact determinants of health and address health disparities at appropriate time points across the life course.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
African American
20+ pack years of smoking
eligible for or received LDCT screening
current smoker
Disqualifiers
N/A
Trial design
Sequential
Treatments tested in this trial
Smoking cessation multilevel Intervention
BehavioralThe intervention will utilize a multilevel intervention based on the Social Ecological Model's individual, institutional, and community levels.
Treatment groups
Trial outcomes
Primary outcomes
Stage of Change for Smoking Cessation
Stage of change in smoking cessation behavior
7-Day Point Prevalence Abstinence Rate
Proportion of participants reporting no smoking in the past 7 days
24-Hour Point Prevalence Abstinence Rate
Proportion of participants reporting no smoking in the past 24 hours
Daily Cigarette Consumption
Number of cigarettes smoked per day
Secondary outcomes
Lung Cancer Screening (LDCT) Uptake
Completion of low-dose computed tomography (LDCT) lung cancer screening, assessed using a validated questionnaire.
Intent to Undergo Lung Cancer Screening
Participant-reported intention to obtain lung cancer screening, assessed using a previously validated questionnaire.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Louisiana State University Health Sciences Center in New Orleans
Lead sponsor
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator